Form 4 for ONC BeOne Medicines Ltd.
Accepted 2026-09-03 17:17:16 ET · period of report 2026-09-01 · accession 0001675628-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-03 17:17 | 2026-09-01 | ONC | Ball Titus B. | Principal Accounting Off | S - Sale | $355.86 | -132 | 0 | -100% | -$47.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares | 2026-09-01 | S | D | 132 | $355.86 | 0 | D | — | — | (F1) Each American Depositary Share represents 13 Ordinary Shares. (F2) The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of August 31, 2023, subject to continued service. |